Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Rhamnosus GG for Alcohol Use Disorder and Alcoholic Hepatitis
NCT05178069Phase 2Recruiting
- Sponsor
- University of Louisville
- Start
- Jun 2022
- Primary completion
- Aug 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in alcohol use disorder (AUD), alcoholic hepatitis (AH), sponsored by University of Louisville. Started Jun 2022; status: recruiting.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
alcohol use disorder (AUD)alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT05178069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05178069.